AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17028353
Drug: sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: sublingual misoprostol 50 micrograms every 4 hours for up to five doses
Trial: 20724487
Drug: Smoothie containing
RxNorm normalized name: CONTAINER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoothie containing 22.5 g blueberry bioactives
Trial: 16088807
Drug: RIX4414 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RIX4414 vaccine (3 concentrations: 10(4.7), 10(5.2), 10(6.1) focus-forming units)
Trial: 11248824
Drug: Ciprofloxacin 0.3%
RxNorm normalized name: Ciprofloxacin 0.3%, Fluocinolone Acetonide 0.025% Otic drops, solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 0.3% ophthalmic solution
Trial: 1928272
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (fortified cefazolin 33 mg/ml and fortified gentamicin or tobramycin 14 mg/ml)
Trial: 29037631
Drug: Bowen Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bowen Therapy
Trial: 26502357
Drug: TAK-385 (0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-385 (0 [placebo], 80, 120, 180, or 360 mg) single doses
Trial: 26502357
Drug: TAK-385 (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-385 (40 [with loading dose], 60, 80, or 160 mg) daily for 28 days
Trial: 26502357
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of TAK‐385 on day 28
Trial: 26502357
Drug: TAK-385 (40-180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAK-385 (40-180 mg/d)
Trial: 22383508
Drug: Oral ascorbic
RxNorm normalized name: ascorbate
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ascorbic acid (Asc) 2-g single dose
Trial: 10761170
Drug: Fluvastatin 40
RxNorm normalized name: fluvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin 40 mg daily for 12 weeks
Trial: 8158539
Drug: Aerosolized pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine (300 mg monthly)
Trial: 8158539
Drug: Low-dose daily
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose daily TMP-SMX (400-80 mg)
Trial: 10663358
Drug: HRT (piperazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (piperazine estrone sulfate 0.625‐0.937 mg daily +/‐ medroxyprogesterone acetate 2.5 mg daily)
Trial: 14633812
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (300 mg/day)
Trial: 12756490
Drug: Selenium and
RxNorm normalized name: Selenium and/or selenium compound
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium and Vitamin E combination
Trial: 18090872
Drug: Oral hormone
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral hormone therapy (conjugated equine estrogens: 0.625 mg/d)
Trial: 6340552
Drug: Enprofylline 2
RxNorm normalized name: Enprofylline
DrugBank: Enprofylline (DB00824)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprofylline 2 mg/kg b.wt.
Trial: 6340552
Drug: Enprofylline 4
RxNorm normalized name: Enprofylline
DrugBank: Enprofylline (DB00824)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enprofylline 4 mg/kg b.wt.
Trial: 29417793
Drug: Oral supplement
RxNorm normalized name: Healios Oral Supplement Unflavored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplement (biotin, probiotic, vitamin E, zinc, nicotinamide; males: beta sitosterol and Boswellia serrata; females: myo‐inositol and folic acid) and topical cream device (verbascoside, Ocimum gratissimum, salicylic acid, gluconolactone, complex alpha‐hydroxy acids)
Trial: 29417793
Drug: Topical cream
RxNorm normalized name: Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical cream device (verbascoside, Ocimum gratissimum, salicylic acid, gluconolactone, complex alpha‐hydroxy acids)
Trial: 29417793
Drug: Oral supplement
RxNorm normalized name: Healios Oral Supplement Unflavored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral supplement
Trial: 25856160
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogen (0.45 mg/day) with intermittent progesterone (200 mg/day for 12 days a month)
Trial: 25856160
Drug: Transdermal 17β‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal 17β‐estradiol (50 µg/day) with intermittent progesterone (200 mg/day for 12 days a month)
Trial: 26508701
Drug: Placebo pills
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo pills and patch
Trial: 25367551
Drug: Ketamine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.15 mg/kg + normal saline 0.05 ml/kg (KET)
Trial: 25367551
Drug: Ketamine 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.15 mg/kg + dexmedetomidine 0.5 μg/kg (KETODEX)
Trial: 25367551
Drug: Placebo (volume-matched
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (volume-matched normal saline 0.15 mL/kg + normal saline 0.05 mL/kg)
Trial: 20500877
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg metoprolol succinate
Trial: 10821991
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg carvedilol
Trial: 15950631
Drug: Utrogest 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Utrogest 200 (200 mg vaginal capsules, three times per day)
Trial: 15950631
Drug: Crinone 8%
RxNorm normalized name: Crinone 8% Vaginal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone 8% (vaginal gel, two times per day)
Trial: 11474769
Drug: New antiepileptic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New antiepileptic drugs (AEDs) such as oxcarbazepine, levetiracetam, zonisamide, lamotrigine, and topiramate
Trial: 9578541
Drug: New antiepileptic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New antiepileptic drugs (AEDs)
Trial: 11474769
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of new AEDs
Trial: 11474769
Drug: First therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: First therapy given to newly diagnosed patients
Trial: 8306268
Drug: IMMU-4 99mTc-Fab'
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IMMU-4 99mTc-Fab' fragments (1 mg, 19.3 mCi average)
Trial: 2471472
Drug: Trimethoprim (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim (200 mg with procainamide dose after 100 mg twice a day for 2 days)
Trial: 377448
Drug: Ketoprofen (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (200 mg/day)
Trial: 28091641
Drug: GnRH analog
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GnRH analog therapy with pomegranate extract
Trial: 21829006
Drug: IM peribulbar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM peribulbar injection
Trial: 20014598
Drug: Ropivacaine 19.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 19.5 mg with fentanyl 20 microg (group R)
Trial: 20014598
Drug: Bupivacaine 13
RxNorm normalized name: bupivacaine 132 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 13 mg with fentanyl 20 microg (group B)
Trial: 15638236
Drug: Infliximab (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (5 mg/kg) administered as three infusions at 0, 2, and 6 weeks, then every 8 weeks
Trial: 15638236
Drug: Methylprednisolone (0.7-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (0.7-1 mg/kg) daily for one week followed by tapering regimen
Trial: 11442865
Drug: Caudal tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal tramadol 2 mg.kg‐1 (group T)
Trial: 11442865
Drug: Caudal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine 0.03 mg.kg‐1 (group M)
Trial: 11442865
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (group C) received morphine sulphate 0.03 mg.kg‐1 at the end of surgery, caudally
Trial: 11442865
Drug: Caudal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine or tramadol (presurgical)
Trial: 11442865
Drug: Caudal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal morphine (postsurgical)
Trial: 34496
Drug: Flurazepam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flurazepam (30 mg)
Trial: 2936352
Drug: Midazolam (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (15 mg)
Trial: 22623385
Drug: Control (C)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (C) group with untreated mushrooms providing 0.85 μg/d ergocalciferol
Trial: 22623385
Drug: M1 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M1 group with UV-treated mushrooms providing 8.8 μg/d ergocalciferol
Trial: 22623385
Drug: M2 group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: M2 group with UV-treated mushrooms providing 17.1 μg/d ergocalciferol
Trial: 11106838
Drug: Antihypertensive medication
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive medication (specifically diuretics)
Trial: 11106838
Drug: Hypertension (BP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertension (BP 160/95 or antihypertensive medication)
Trial: 8797128
Drug: Fosinopril 20
RxNorm normalized name: fosinopril 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril 20 mg (increased to 40 mg after 8 weeks, average 25.6 mg)
Trial: 8427433
Drug: MPC (meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MPC (meperidine 2 mg/kg + promethazine 1 mg/kg + chlorpromazine)
Trial: 8427433
Drug: MP (meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP (meperidine 2 mg/kg + promethazine 1 mg/kg)
Trial: 3592208
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg ketamine intravenously
Trial: 3592208
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg ketamine intravenously
Trial: 12546253
Drug: Capitated Assertive
RxNorm normalized name: Lespedeza capitata flowering top extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capitated Assertive Community Treatment (ACT) program
Trial: 10230169
Drug: Caffeinated soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated soft drink (CC)
Trial: 9506802
Drug: Isotonic carbohydrate‐electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic carbohydrate‐electrolyte solution (CES)
Trial: 19178101
Drug: Fluoride gel
RxNorm normalized name: Sodium Fluoride Gel
DrugBank: Sodium fluorophosphate (DB09484)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoride gel applications (Test group B, n = 118)
Trial: 1632174
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion and dextropropoxyfen per os
Trial: 31675083
Drug: Incentive group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incentive group (lottery-based incentive tied to daily self-weighing)
Trial: 31675083
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (weekly messages)
Trial: 9927098
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ipratropium bromide and albuterol sulfate
Trial: 9927098
Drug: Albuterol base
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol base alone (control)
Trial: 7485698
Drug: Ro 46‐2717
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 46‐2717 and Ro 46‐2924 vaccines (after third immunization)
Trial: 7388852
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment with lignocaine, procainamide, and practolol
Trial: 31415378
Drug: Dexmedetomidine (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (loading dose, 1 μg/kg for 10 minutes and continuous infusion, 0.4 μg/kg/hr)
Trial: 25854015
Drug: Western medication
RxNorm normalized name: Western wheatgrass
DrugBank: Pascopyrum smithii pollen (DB10719)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medication (Fluoxetine)
Trial: 21454742
Drug: rhBMP-2/ACS (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhBMP-2/ACS (1.5 mg/mL, total 12.0 mg)
Trial: 16800837
Drug: Once-monthly ibandronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-monthly ibandronate plus patient support programme (PSP)
Trial: 16368038
Drug: Once-weekly alendronate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly alendronate
Trial: 15090625
Drug: Standard diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard diet (400 to 500 mg of dietary calcium/d supplemented with placebo)
Trial: 9380804
Drug: Euclamin 20
RxNorm normalized name: Eucamint
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euclamin 20 mg + intermediate insulin (M3)
Trial: 9380804
Drug: Euclamine 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Euclamine 20 mg + intermediate insulin (M4)
Trial: 28139568
Drug: Alternative treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternative treatments
Trial: 21992869
Drug: Brief telephone
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Brief telephone intervention plus treatment as usual
Trial: 12832240
Drug: Olanzapine (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine (5-20 mg/day)
Trial: 17126974
Drug: Fluphenazine (6-21
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluphenazine (6-21 mg/day)
Trial: 12015629
Drug: Carbohydrate-electrolyte solution
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-electrolyte solution (46 +/- 1 g) during the run (M+C)
Trial: 12015629
Drug: Carbohydrate-electrolyte solution
RxNorm normalized name: CARBOHYDRATE/ELECTROLYTES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate-electrolyte solution (M+C)
Trial: 22203319
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.3 mg/kg
Trial: 8326053
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.6 mg/kg
Trial: 7649958
Drug: Methylphenidate (MPH)
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate (MPH) 0.9 mg/kg
Trial: 2666335
Drug: Intravenous (I.V.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (I.V.) metronidazole
Trial: 2666335
Drug: Intravenous (I.V.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (I.V.) metronidazole-gentamicin-ampicillin
Trial: 812456
Drug: Immediate postoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate postoperative parenteral hyperalimentation
Trial: 31806216
Drug: Warfarin triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin triple therapy
Trial: 23395257
Drug: Alfacalcidol 0.25
RxNorm normalized name: alfacalcidol 0.25 MCG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol 0.25 μg twice daily
Trial: 11880840
Drug: Spinal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal morphine 20 microgram/kg
Trial: 11880840
Drug: Spinal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spinal morphine 10 microgram/kg
Trial: 7604646
Drug: 10 mg/d
RxNorm normalized name: Arixtra 10 mg/dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/d cetirizine
Trial: 7604646
Drug: 20 mg/d
RxNorm normalized name: Valtoco, 20 mg/dose nasal spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/d cetirizine
Trial: 7604646
Drug: cetirizine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cetirizine (10 mg/d or 20 mg/d)
Trial: 2672989
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% (1 ml/kg)
Trial: 2672989
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% or 0.5% (Age (years +2)/10 ml per dermatome)
Trial: 8999618
Drug: Formoterol 12
RxNorm normalized name: formoterol 12 mcg inhalation capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol 12 micrograms twice daily
Trial: 2238755
Drug: Pancreatin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pancreatin (6 x 2 capsules, 6 x 300 mg/d)
Trial: 30224341
Drug: High plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High plasma VEGF-A levels (>5.1 pg/mL)
Trial: 27939574
Drug: Pregabalin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pregabalin (150 mg capsule orally, 1 hour before surgery and 75 mg twice a day for 2 days postoperatively)
Trial: 27939574
Drug: Control (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (2 similar-looking multivitamin capsules)
Trial: 21317170
Drug: teduglutide 0.10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teduglutide 0.10 mg/kg/day
Trial: 21317170
Drug: teduglutide 0.05
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teduglutide 0.05 mg/kg/day
Trial: 21317170
Drug: teduglutide (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teduglutide (both doses)
Trial: 18705947
Drug: High-dose human
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose human albumin (2 g/kg) administered in a 2-hour intravenous infusion within 5 hours of symptom onset
Trial: 11451176
Drug: Induction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Induction treatment (daily dose of interferon) with ribavirin 1,000-1,200 mg
Trial: 11451176
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (interferon thrice weekly) with ribavirin 1,000-1,200 mg
Trial: 8152279
Drug: Interferon (IFN)
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon (IFN) based treatment regimens
Trial: 8152279
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy or IFN-monotherapy
Trial: 27547925
Drug: Autologous fecal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autologous fecal microbiota transplantation (FMT) administered by colonoscopy
Trial: 11921013
Drug: Combined modality
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined modality treatment for limited stage Hodgkin's lymphoma
Trial: 389148
Drug: EMG feedback
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EMG feedback therapy
Trial: 27567897
Drug: Intensive medical
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive medical therapy (IMT)
Trial: 8824654
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg q.d.s.
Trial: 12697594
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 0.1 mg
Trial: 12697594
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 0.2 mg
Trial: 30954338
Drug: IV and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV and topical tranexamic acid (TXA)
Trial: 26616409
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (3 mg/kg/twice a day of zinc sulfate monohydrate orally for 10 days)
Trial: 26616409
Drug: Standard antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard antibiotic treatment without zinc (Control)
Trial: 20522733
Drug: High-dose EPO
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose EPO (30,000 IU/day for 3 days)
Trial: 20522733
Drug: Low-dose EPO
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose EPO (5,000 IU/week for 3 months)
Trial: 18972289
Drug: MF‐DPI 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MF‐DPI 400 microg QD PM (1 inhalation)
Trial: 15906422
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg (single oral dose)
Trial: 3300241
Drug: Nitrendipine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (20 mg/day)
Trial: 31511031
Drug: Eutropin (0.24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eutropin (0.24 mg/kg/week, 6 times/week)
Trial: 31511031
Drug: Comparator (Genotropin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparator (Genotropin, 0.24 mg/kg/week, 6 times/week)